Machine-learning Algorithm to Differentiate Intraoperative Ketamine Dosing Based on Electroencephalographic Density Spectrum Array Analysis
1 other identifier
observational
90
1 country
1
Brief Summary
Ketamine is widely used in the setting of multimodal general anesthesia, and the Electroencephalographic density spectral array (DSA) monitoring has been implemented in the practice of anesthesia. The purpose of this study is to investigate the dose-response EEG changes in patients during the perioperative period when ketamine is used. With the application of machine-learning algorithm, we aim to interpret the ketamine dosing precisely and accurately, based on the DSA obtained.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 15, 2022
CompletedFirst Posted
Study publicly available on registry
February 25, 2022
CompletedStudy Start
First participant enrolled
March 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedAugust 17, 2022
August 1, 2022
10 months
February 15, 2022
August 15, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ketamine dosing based on EEG DSA
The DSA is obtained from raw EEG by fast Fourier transformation. By interpreting the DSA, we can obtain the trends and changes of power within different frequencies over time, in respect to different ketamine dosing.
DSA EEG is placed before anesthesia starts, recorded throughout the operative procedure until emergence and patient is extubated. The saved EEG DSA data will be retrieved by the end of the day.
Study Arms (3)
Control group
Sevoflurane
Low dose ketamine group
Sevoflurane + 3µg/kg/min ketamine infusion
High dose ketamine group
Sevoflurane + 6µg/kg/min ketamine infusion
Interventions
Ketamine infusion at different dose to observe EEG DSA changes
Eligibility Criteria
Patients admitted for spine surgery under the department of orthopedic surgery at VGHTPE, a tertiary hospital in Taiwan, will be selected.
You may qualify if:
- Patients undergoing elective spine surgery
- Aged 20-80 years old
You may not qualify if:
- Pregnancy
- Presence of major brain disorders: stroke, epilepsy, Parkinson's disease, etc.
- Any of the following major organ disorders:
- Chronic pulmonary disease (Clinically diagnosed severe chronic obstructive pulmonary disease or FEV1/FVC \<70% or FEV1 \<50%)
- Heart failure (NYHA III or IV)
- Chronic renal failure (eGFR\<60ml/min/1.73m2)
- Ongoing sepsis or infection
- Ongoing of history of CNS-acting medications/substances use (e.g.: sedatives, hypnotics, stimulants, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taipei Veterans General Hospital
Taipei, Beitou, 112, Taiwan
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Chien-Kun Ting, MD, PhD
Taipei Veterans General Hospital, Taiwan
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 15, 2022
First Posted
February 25, 2022
Study Start
March 1, 2022
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
August 17, 2022
Record last verified: 2022-08